Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Fascicoli precedenti > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 April;54(2) > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 April;54(2):230-40

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti

THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


eTOC

 

REVIEWS  NUCLEAR CARDIOLOGY AT THE EVE OF THE NEW DECADE


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2010 April;54(2):230-40

Copyright © 2010 EDIZIONI MINERVA MEDICA

lingua: Inglese

Molecular imaging in nuclear cardiology: translating research concepts into clinical applica-tions

Sinusas A. J.

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA


PDF  


Molecular imaging provides a novel approach for the early non-invasive detection of critical molecular or cellular processes associated with initiation of disease, before the manifestation of anatomical changes or late physiological consequences. This article reviews the current and future role of molecular imaging in evaluation of cardiovascular diseases, including the early detection of atherosclerosis, ischemia-induced angiogenesis, and post-infarction left ventricular remodeling. Cardiova-scular molecular imaging with radiolabeled probes has already translated into clinical practice in the evaluation of critical metabolic and receptor mediated process in the heart, however, the true clinical impact of targeted molecular imaging has not yet been realized. The advancement of cardiovascular molecular imaging will require the development of novel targeted probes, hybrid high-sensitivity and high-resolution imaging systems, and the collaboration of basic and clinical imaging communities. The application of molecular imaging in combination with conventional anatomical and physiological imaging should provide new insights into the pathophysiology of disease that may allow a more personalized approach to the evaluation and management of cardiovascular diseases.

inizio pagina

Publication History

Per citare questo articolo

Corresponding author e-mail

albert.sinusas@yale.edu